| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 3.952.454 $ | 95,20 | 253.681 | |||||||
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 493.589 $ | 11,89 | 13.431 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 480.120 $ | 11,56 | 522 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 281.241 $ | 6,77 | 364 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 260.369 $ | 6,27 | 740 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 248.982 $ | 6,00 | 4.600 | |
| CSPC Pharmaceutical Group Ltd | CSPC Pharmaceutical Group Ltd | EC | HK1093012172 | Long | Börsenkurs (Stufe 1) | 208.923 $ | 5,03 | 180.000 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 206.095 $ | 4,96 | 3.287 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 197.263 $ | 4,75 | 907 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 193.276 $ | 4,66 | 980 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 191.730 $ | 4,62 | 6.828 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 185.968 $ | 4,48 | 1.546 | |
| Shionogi & Co Ltd | Shionogi & Co Ltd | EC | JP3347200002 | Long | Börsenkurs (Stufe 1) | 185.345 $ | 4,46 | 8.500 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Börsenkurs (Stufe 1) | 185.244 $ | 4,46 | 473 | |
| Innovent Biologics Inc | Innovent Biologics Inc | EC | KYG4818G1010 | Long | Börsenkurs (Stufe 1) | 184.090 $ | 4,43 | 17.000 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 98.566 $ | 2,37 | 2.005 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 91.698 $ | 2,21 | 2.818 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 83.772 $ | 2,02 | 1.738 | |
| Zealand Pharma A/S | Zealand Pharma A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 72.051 $ | 1,74 | 1.584 | |
| Hanmi Pharm Co Ltd | Hanmi Pharm Co Ltd | EC | KR7128940004 | Long | Börsenkurs (Stufe 1) | 53.126 $ | 1,28 | 158 | |
| Jiangsu Hengrui Pharmaceutical | Jiangsu Hengrui Pharmaceuticals Co Ltd | EC | CNE100006XS6 | Long | Börsenkurs (Stufe 1) | 51.006 $ | 1,23 | 6.200 | |
| 3.952.454 $ | 95,20 | 253.681 |